Agreed, and this move by WHO is the first time in months/years that I have contemplated even better results in the DCVax-l trial than what I’ve assumed previously.
Agreed. And I would think this reclassification probably makes you more comfortable as I know you had earlier expressed some concerns by the lack of clarity regarding the pro neural set.
Market Data 
Markets 
AI
